Method for the preparation of mirtazapine intermediates

Details for Australian Patent Application No. 2002247130 (hide)

Owner TEVA PHARMACEUTICAL INDUS- TRIES LTD.

Inventors Wizel, Shlomit; Metzger, Leonid

Agent Shelston IP

Pub. Number AU-A-2002247130

PCT Pub. Number WO2002/070513

Priority 60/272,699 01.03.01 US

Filing date 14 February 2002

Wipo publication date 19 September 2002

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 487/12 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002247130

24 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002247131-SKIN CARE COMPOSITION WITH RETINYL ESTER AS VITAMIN A PROPIONATE, RETINYL PALMITATE, dALPHA TOCOPHEROL, RICE AMINO ACIDS AND LIPOSOMES, AND METHOD OF APPLICATION

2002247129-Histidine proline rich glycoprotein (HPRG) as an anti-angiogenic and anti-tumor agent